Editorial series
Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors
theheart.org forumExchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Most popular
- Dabigatran "real-life" results suggest caution needed
- Girl trouble: Rising tide of STEMI in young women "clearly not acceptable"
- How low should you go? Experts debate latest salvo in the war on sodium
- BP reductions with renal denervation durable to 30 months: SYMPLICITY HTN-2
- Dietary saturated fat has undeserved bad reputation, says review
- SCAAR: Could cheap heparin replace pricy bivalirudin in PCI for non-STE-ACS?
- Hormone therapy associated with MI in male-to-female transsexuals
- Apixaban superior to warfarin across range of INR values, ARISTOTLE analysis
- No benefit of fish oil in high-risk patients
- Repeat ablation wins out over antiarrhythmic agents for recurrent paroxysmal AF
- Why Does the QRS Morphology Change?
- Girl trouble: Rising tide of STEMI in young women "clearly not acceptable"
- Disagreeing with an influential thought leader on ICD use
- Dietary saturated fat has undeserved bad reputation, says review
- What can you conclude from these images?
- How low should you go? Experts debate latest salvo in the war on sodium
- Hatha yoga reduces blood pressure in mildly hypertensive patients
- Oral anticoagulants less used in paroxysmal than persistent AF: NCDR data
- No benefit of fish oil in high-risk patients
- Dabigatran "real-life" results suggest caution needed
Test your knowledge
RELEASE DATE: Jan 09, 2013 11:05 AM EST
RELEASE DATE: Feb 12, 2013 10:00 AM EST
RELEASE DATE: Apr 15, 2013 3:50 PM EDT
Trial slides of the month
Overviews of top trials including background, results, and commentaries
- HPS2-THRIVE (Niacin/Laropiprant vs Placebo for Raising HDL Cholesterol)
- PEITHO (Tenectaplase plus Heparin vs Heparin Alone in Pulmonary Embolism)
- CHAMPION-PHOENIX (IV Cangrelor vs Oral Clopidogrel for the Management of Periprocedural PCI Complications)
- STREAM (Tenectaplase plus Antithrombotic Therapy vs Primary PCI in STEMI)
- TERISA (Ranolazine vs Placebo in Diabetic Patients with Angina)
































